Patent Application
Utility
App. No. 18/473,935
· Confirmation No. 5229
GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
Applicant:
Jazz Pharmaceuticals Ireland Limited
Abandoned -- Incomplete Application (Pre-examination)
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2024-06-11 | ABN |
Abandonment | 2 | View | |
| 2024-05-08 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-05-08 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2024-05-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-01-19 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2023-10-10 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2023-10-10 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-10-10 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2023-10-10 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2023-09-25 | OATH |
Oath or Declaration filed | 2 | View | |
| 2023-09-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-09-25 | ADS |
Application Data Sheet | 9 | View | |
| 2023-09-25 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2023-09-25 | PA.. |
Power of Attorney | 2 | View | |
| 2023-09-25 | SPEC |
Specification | 40 | View | |
| 2023-09-25 | CLM |
Claims | 4 | View | |
| 2023-09-25 | ABST |
Abstract | 1 | View |
Inventors
Clark ALLPHIN
Seattle, WA
Scott BURA
Gilroy, CA
Attorneys & Agents of Record
Classification
USPC
424/497
A61K31/19
A61K9/5031
A61K31/785
A61K38/02
Prosecution
- Art Unit
- 1617
- Customer No.
- 128521
- Docket No.
- JAZZ-025/09US 306882-2717
- Confirmation No.
- 5229
Publication
- Pub. No.
- US20240016770A1
- Pub. Date
- 2024-01-18
Parent
is a Continuation of
→
App. 18/160,881
Filed 2023-01-27
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/838,527
Filed 2022-06-13
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/222,579
· US 11,364,215
Filed 2021-04-05
· Patented Case
Parent
is a Continuation of
→
App. 17/210,064
· US 11,147,782
Filed 2021-03-23
· Patented Case
Parent
is a Continuation of
→
App. 17/118,041
· US 11,077,079
Filed 2020-12-10
· Patented Case
Parent
is a Continuation of
→
App. 16/448,598
Filed 2019-06-21
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/047,586
· US 10,398,662
Filed 2016-02-18
· Patented Case
Parent
Claims priority from a provisional application
→
App. 62/117,889
Filed 2015-02-18
· Provisional Application Expired
Child
is a Continuation of
→
App. 19/572,479
Filed 2026-03-19
· Application Undergoing Preexam Processing
Child
is a Continuation of
→
App. 18/657,999
Filed 2024-05-08
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 18/989,440
Filed 2024-12-20
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 19/292,290
Filed 2025-08-06
· Abandoned -- Incomplete Application (Pre-examination)
from
CAVION, INC.,
CELATOR PHARMACEUTICALS, INC.,
GW PHARMA LIMITED,
JAZZ PHARMACEUTICALS IRELAND LIMITED,
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (F/K/A GW RESEARCH LIMITED),
JAZZ PHARMACEUTICALS, INC.
SECURITY AGREEMENT
Recorded 2024-07-26
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-05-14
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-05-14
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 18/473,935
- Filed
- 2023-09-25
- Pub. No.
- US20240016770A1
- Art Unit
- 1617
External Links